年度业绩和2022年第四季度
Wednesday, February 01, 2023

媒体发布:

英文(PDF 0.3 MB) | 多伊奇(PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.5 MB)

观看网络直播

Download the presentation (PDF 5.1 MB)

Download the podcast (MP3 45 MB)

Read the presentation transcript

澳门葡京赌场注册制药 环境、社会和治理 Update Q4 2022 (PDF 0.9 MB)
 

关键人物1 Q4 2022
(美元)		 Q4 2021
(美元)		 变化百分比
(美元/ cc)
净销售额 12,690 13,229 -4 (cc: 3)
营业收入 1,949 2,562 -24 (cc: -14)
净收益 1,466 16,306 -91 (cc: -90)
每股收益(美元) 0.69 7.29 -91 (cc: -89)
自由现金流 3,552 3,027 17

核心		      
营业收入 4,030 3,819 6 (cc: 15)
净收益 3,251 3,135 4 (cc: 14)
每股收益(美元) 1.52 1.40 9 (cc: 19)
  1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 50 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

Q3 2022 results - Tuesday, October 25, 2022

媒体发布:

英文(PDF 0.3 MB) | 多伊奇(PDF 0.3 MB) | Français (PDF 0.3 MB)

Interim financial report (PDF 0.5 MB)

观看网络直播

Download the presentation (PDF 3.7 MB)

Download the podcast (MP3 40 MB)

Read the presentation transcript

澳门葡京赌场注册制药 环境、社会和治理 Update - October 31, 2022 (PDF 0.5 MB)
 

关键人物1 Q3 2022
(美元)		 Q3 2021
(美元)		 变化百分比
(美元/ cc)
净销售额 12,543 13,030 -4 (cc: 4)
营业收入 2,168 3,233 -33 (cc: -23)
净收益 1,575 2,758 -43 (cc: -33)
每股收益(美元) 0.73 1.23 -41 (cc: -31)
自由现金流 4,169 4,423 -6

核心		      
营业收入 4,282 4,467 -4 (cc: 5)
净收益 3,419 3,830 -11 (cc: -2)
每股收益(美元) 1.58 1.71 -8 (cc: 1)
  1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 49 of the Condensed Interim Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

 

Q2 2022 results - Tuesday, July 19, 2022

媒体发布:

英文(PDF 0.2 MB) | 多伊奇(PDF 0.2 MB) | Français (PDF 0.2 MB)

Interim financial report (PDF 0.5 MB)

观看网络直播

Download the interactive presentation (PDF 2.9 MB)

Download the podcast (MP3 42 MB)

Read the presentation transcript

澳门葡京赌场注册制药 环境、社会和治理 Update - July 20, 2022 (PDF 0.4 MB)

关键人物1

  Q2 2022
(美元)		 Q2 2021
(美元)		 变化百分比
(美元/ cc)
净销售额 12,781 12,956 -1 (cc: 5)
营业收入 2,228 3,479 -36 (cc: -30)
净收益 1,695 2,895 -41 (cc: -34)
每股收益(美元) 0.77 1.29 -40 (cc: -33)
自由现金流 3,304 4,235 -22

核心		      
营业收入 4,270 4,345 -2 (cc: 5)
净收益 3,431 3,716 -8 (cc: -1)
每股收益(美元) 1.56 1.66 -6 (cc: 1)
  1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 48 of the Condensed Interim Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

Q1 2022 results - Tuesday, April 26, 2022

媒体发布:

英文(PDF 0.2 MB) | 多伊奇(PDF 0.2 MB) | Français (PDF 0.2 MB)

Interim financial report (PDF 0.4 MB)

观看网络直播

Download the interactive presentation (PDF 4.1 MB)

Download the podcast (MP3 40 MB)

Read the presentation transcript

澳门葡京赌场注册制药 环境、社会和治理 Update - April 27, 2022 (PDF 0.7 MB)


关键人物1

  Excluding Roche investment impacts2 报道
  Q1 2022
(美元)		 Q1 2021
(美元)		 变化百分比
(美元/ cc)		 Q1 2021
(美元)		 变化百分比
(美元/ cc)
净销售额 12,531 12,411 1 (cc: 5) 12,411 1 (cc: 5)
营业收入 2,852 2,415 18 (cc: 26) 2,415 18 (cc: 26)
净收益 2,219 1,803 23 (cc: 32) 2,059 8 (cc: 15)
每股收益(美元) 1.00 0.80 25 (cc: 34) 0.91 10 (cc: 17)
自由现金流 920 1,075 -14 1,597 -42

核心		          
营业收入 4,083 3,957 3 (cc: 9) 3,957 3 (cc: 9)
净收益 3,251 3,100 5 (cc: 11) 3,413 -5 (cc: 0)
每股收益(美元) 1.46 1.38 6 (cc: 12) 1.52 -4 (cc: 2)
  1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 35 of the Condensed Interim Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.
  2. A reconciliation of 2021 IFRS results and non-IFRS measures core results and free cash flow to exclude the impacts of the 2021 divestment of our Roche investment can be found on page 40 of the Condensed Interim Financial Report. The free cash flow impact represents the dividend received in Q1 2021 from Roche in relation to the distribution of its 2020 net income.

Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the 澳门葡京赌场注册制药 website for historical purposes only. 澳门葡京赌场注册制药 assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.